NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 27.15-0.59 (-2.13%) At close: 04:00PM EST. ... Intellia Therapeutics, Inc., a genome editing company ...3 days ago · Intellia Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Feb 21, 2024 6:22 a.m. EST Delayed quote $ 27.27 0.12 0.44% Before Hours Volume: 480 Advanced Charting... Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price. Feb 8, 2024 · The 17 analysts with 12-month price forecasts for NTLA stock have an average target of 76.76, with a low estimate of 40 and a high estimate of 136. The average target predicts an increase of 179.43% from the current stock price of 27.47. 4 days ago · Feb. 15. MT. Morgan Stanley Adjusts Intellia Therapeutics' Price Target to $85 From $90, Keeps Overweight Rating. Nov. 13. MT. Oppenheimer Slashes Price Target on Intellia Therapeutics to $70 From $80, Maintains Outperform Rating. Nov. 13. MT. Goldman Sachs Adjusts Price Target on Intellia Therapeutics to $136 From $157, Maintains Buy Rating. Price Target. Based on short-term price targets offered by 23 analysts, the average price target for Intellia Therapeutics, Inc. comes to $77.61. The forecasts range from a low of $29.00 to a high ...Intellia Therapeutics, Inc. price-consensus-chart | Intellia Therapeutics, Inc. Quote. Zacks Rank & Stocks to Consider. Currently, Intellia has a Zacks Rank #3 (Hold).Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price.On Friday, Canaccord Genuity (TSX: CF) maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.18 Oct 2023 ... The Food and Drug Administration gave Intellia Therapeutics (NTLA) the go-ahead to begin a pivotal study of its gene-editing treatment for a ...Feb 7, 2024 · What was the 52-week low for Intellia Therapeutics stock? The low in the last 52 weeks of Intellia Therapeutics stock was 22.67. According to the current price, Intellia Therapeutics is 115.82% ... Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics. By Alex Carchidi – Jan 21, 2024 at 8:00AM ... Current Price. $27.18. Price as of February 22, 2024, 4:00 p.m. ET.18 Mar 2021 ... The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a solid ...Intellia Therapeutics (NASDAQ: NTLA) $26.45. (-10.7%) -$3.16. Price as of February 13, 2024, 4:00 p.m. ET. You’re reading a free stock page from The Motley Fool’s Premium …Feb 17, 2024 · Wall Street analysts are quite bullish about Intellia Therapeutics (NASDAQ: NTLA) stock. On average, they're estimating that it'll rise by around 157% within the next …3 days ago · View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 26.10-1. ...Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 2.9% so far this month. During the month of December, Intellia Therapeutics Inc’s stock price has reached a high of $33.60 and a low of $26.95. Over the last year, Intellia Therapeutics Inc has hit prices as high as $47.48 and as low as $22.67 ...View a financial market summary for NTLA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to NTLA (Intellia Therapeutics) stock. ... What is Intellia Therapeutics stock price doing today? As of February 23, 2024, NTLA stock price declined to $26.10 with …Jan 21, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intellia Therapeutics wasn't one of them. The 10 stocks that ... Jan 21, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intellia Therapeutics wasn't one of them. The 10 stocks that ... Real-time Price Updates for Intellia Thera CS (NTLA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreOn that note, Editas Medicine ( EDIT 3.38%) and Intellia Therapeutics ( NTLA 2.42%) are both exciting gene-editing businesses that aspire to treat or cure human illnesses using some of the most ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...The current price of NTLA is $28.23. The 52 week high of NTLA is $47.48 and 52 week low is $22.67. When is next earnings date of Intellia Therapeutics Inc (NTLA)? The next earnings date of Intellia Therapeutics Inc (NTLA) is 2024-02-23 Est..Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 …The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31% fall in a month while it is down 34% over the ...Mar 3, 2022 · Intellia Therapeutics. Market Cap. $2B. Today's Change. (-2.13%) -$0.59. Current Price. $27.15. Price as of February 20, 2024, 4:00 p.m. ET. You’re reading a free article with opinions that may ... Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine. Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing.Intellia Therapeutics (NTLA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.r/IntelliaTherapeutics: Unofficial - Intellia Therapeutics Stock Message Board on Reddit. CRISPR technology and stock prices discussion. When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.About the Intellia Therapeutics, Inc. stock forecast. As of 2024 February 18, Sunday current price of NTLA stock is 27.720$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Intellia Therapeutics stock price has been showing a declining tendency so we believe that similar market …Get Intellia Therapeutics Inc (NTLA.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments6 Feb 2023 ... ... price 50:48 Final thoughts 54:32 Get the models on GitHub for FREE ... Revolutionary CRISPR Therapy Tool | Martin Shkreli Analyses Intellia ...RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating Nov. 10: MT Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3 ... Stock Intellia Therapeutics, Inc. …Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 2.9% so far this month. During the month of December, Intellia Therapeutics Inc’s stock price has reached a high of $33.60 and a low of $26.95. Over the last year, Intellia Therapeutics Inc has hit prices as high as $47.48 and as low as $22.67 ...Feb 16, 2024 · NTLA, Intellia Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines 18 Mar 2021 ... The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a solid ...Intellia Contacts: Investors: Ian Karp Senior Vice President, Investor Relations and Corporate Communications ... and got the Nvidia logo tattooed on his shoulder when the stock price hit $100.02/22/2024. Intellia Therapeutics stock price stood at $27.18. According to the latest long-term forecast, Intellia Therapeutics price will hit $30 by the end of 2024 and then $40 by the middle of 2025. Intellia Therapeutics will rise to $45 within the year of 2026, $55 in 2027, $65 in 2028, $75 in 2029, $85 in 2030, $90 in 2032, $95 in 2033 and $100 …Price Target. Based on short-term price targets offered by 23 analysts, the average price target for Intellia Therapeutics, Inc. comes to $77.61. The forecasts range from a low of $29.00 to a high ...04:03 PM ET 03/02/2023. The Food and Drug Administration cleared Intellia Therapeutics ( NTLA) to begin testing its CRISPR gene-editing technology in people on Thursday, leading NTLA stock to jump ...Intellia Therapeutics (NTLA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.Jan 18, 2024 · Intellia Therapeutics, Inc. (NTLA Quick Quote NTLA - Free Report) is a clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. About the Intellia Therapeutics, Inc. stock forecast. As of 2024 February 18, Sunday current price of NTLA stock is 27.720$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Intellia Therapeutics stock price has been showing a declining tendency so we believe that similar market …Intellia Therapeutics. Market Cap. $2B. Today's Change. (-0.99%) -$0.27. Current Price. $26.88. Price as of February 21, 2024, 4:00 p.m. ET. You’re reading a free article with opinions that may ...6 days ago · 2. Intellia Therapeutics. Intellia currently makes up a little more than 3% of Wood's healthcare fund, as the 14 th largest position. The company doesn't yet have a …Intellia Therapeutics Stock Price Prediction 2024, 2025 - 2028. Moderna Price Prediction Tomorrow & Month. In 2 weeks Intellia Therapeutics stock prediction on Thursday, February, 22: 26.39 dollars, maximum 28.50, minimum 24.28. Intellia Therapeutics stock price forecast on Friday, February, 23: 25.64 dollars, maximum 27.69, minimum 23.59.5 May 2016 ... Intellia's common stock is expected to begin trading on the NASDAQ Global Market under the ticker symbol "NTLA" on May 6, 2016 . Credit Suisse , ....Wall Street analysts are quite bullish about Intellia Therapeutics (NTLA-2.84%) stock. On average, they're estimating that it'll rise by around 157% within the next 12 months. In the context of ...NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...View Intellia Therapeutics (NTLA) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo.Feb 14, 2024 · View Intellia Therapeutics, Inc. NTLA stock quote prices, financial information, real-time forecasts, and company news from CNN.A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.18 Oct 2023 ... The Food and Drug Administration gave Intellia Therapeutics (NTLA) the go-ahead to begin a pivotal study of its gene-editing treatment for a ...Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course ...5 days ago · See the latest Intellia Therapeutics Inc stock price (NTLA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.These 4 analysts have an average price target of $80.75 versus the current price of Intellia Therapeutics at $23.64, implying upside. Below is a summary of how these 4 analysts rated Intellia ...NTLA - Intellia Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)On Friday, Goldman Sachs adjusted its stance on Intellia Therapeutics (NASDAQ:NTLA), downgrading the stock from Buy to Neutral and setting a new price target of $32.00. The change follows Intellia ...On Friday, Canaccord Genuity (TSX: CF) maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Intellia Therapeutics (NTLA) Stock Chart & Stock Price History. $27.74. -0.73 (-2.56%) (As of 02/16/2024 ET) Compare. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.3 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:) and slightly increased the price target to $73 from $72. The adjustment follows Intellia’s fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement. 3 days ago · Based on short-term price targets offered by 23 analysts, the average price target for Intellia Therapeutics, Inc. comes to $77.61. The forecasts range from a low of $29.00 to a high of $145.00. Jan 18, 2024 · Intellia Therapeutics, Inc. (NTLA Quick Quote NTLA - Free Report) is a clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. Intellia Therapeutics, Inc. Common Stock (NTLA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. 5 days ago · Intellia Therapeutics Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $27.15 -0.59 (-2.13%) Updated Feb 20, 2024 1W + 2.65% 1M + …Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) and slightly increased the price target to $73 from $72. The adjustment …
The above is based on 19 Wall Street analysts offering 12-month price targets for Intellia in the last 3 months. The average price target is $173.11 with a high forecast of $238.00 and a low .... How much can you borrow from cash app
Jan 4, 2024 · Intellia Contacts: Investors: Ian Karp Senior Vice President, Investor Relations and Corporate Communications ... and got the Nvidia logo tattooed on his shoulder when the stock price hit $100. Intellia Thera CS (NTLA) $27.15 0.59 (2.13%) 16:00 EST NTLA Stock Quote Delayed 30 Minutes.4 days ago · Intellia Therapeutics, Inc. (NTLA) Stock Price | Stock Quote Nasdaq - MarketScreener INTELLIA THERAPEUTICS, INC. PDF Report Equities NTLA …Intellia Contacts: Investors: Ian Karp Senior Vice President, Investor Relations and Corporate Communications ... and got the Nvidia logo tattooed on his shoulder when the stock price hit $100.NTLA Intellia Therapeutics · High. 27.900 · Low. 26.010 · Volume. 922.77K · Open. 26.340 · Pre Close. 26.070 · Turnover. 24.99M · T...Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 18.28% so far this month. During the month of November, Intellia Therapeutics Inc’s stock price has reached a high of $32.39 and a low of $22.67. Over the last year, Intellia Therapeutics Inc has hit prices as high as $51.94 and as low as $22.67 ...Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.2 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) and slightly increased the price target to $73 from $72. The adjustment follows Intellia's fourth ... What this means: InvestorsObserver gives Intellia Thera CS (NTLA) an overall rank of 43, which is below average. Intellia Thera CS is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 43 means that 57% of stocks appear more favorable to our system.5 days ago · See the latest Intellia Therapeutics Inc stock price (NTLA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.28 Oct 2023 ... So (depending on pricing) Intellia may find it tough both to get insurers to cover its medicine, and to find patients willing to pay if they're ...Jan 19, 2024 · Intellia Therapeutics, Inc. (38I.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics, Inc. | Börse Stuttgart ... Intellia Therapeutics (NTLA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. .